Alleged Testimony Claims Ivermectin Could Have Prevented Millions of Deaths

In a shocking revelation, Mary Talley Bowden MD took to twitter to share alleged testimony from Dr. Pierre Kory, claiming that the war on ivermectin may have led to millions of deaths that could have been prevented. According to the tweet, Dr. Kory testified at the Oklahoma state legislature, stating that a safe drug showing an 81% decrease in mortality could have made a significant impact on the outcome for those in the ICU dying of COVID-19.

The tweet, posted on October 21, 2024, poses a thought-provoking question: “If you were in the ICU dying of COVID, would you refuse to try a safe drug showing an 81% decrease in mortality?” This question raises concerns about the potential benefits of ivermectin in treating COVID-19 and calls into question the decisions made by healthcare authorities in their approach to the pandemic.

It is important to note that this information is presented as alleged testimony and has not been independently verified. However, the tweet provides a link to the source of the information, allowing readers to further investigate the claims made by Dr. Kory at the Oklahoma state legislature.

The controversy surrounding ivermectin as a potential treatment for COVID-19 has been a topic of debate throughout the pandemic. While some studies have suggested that ivermectin may have beneficial effects in reducing the severity of the disease, health authorities have been cautious in recommending its use due to a lack of conclusive evidence.

As the world continues to grapple with the ongoing COVID-19 pandemic, the role of treatments like ivermectin in mitigating the impact of the virus remains a subject of interest and debate. The claims made by Dr. Kory, if proven to be true, could have significant implications for the approach to managing the pandemic and saving lives.

In conclusion, the alleged testimony shared on Twitter by Mary Talley Bowden MD raises important questions about the potential benefits of ivermectin in treating COVID-19 and the decisions made by healthcare authorities in their response to the pandemic. Further investigation and research are needed to determine the validity of these claims and to assess the impact of ivermectin on reducing mortality rates among COVID-19 patients.

If you were in the ICU dying of C0VID, would you refuse to try a safe drug showing 81% decrease in mortality?

The war on ivermectin led to millions of deaths.@PierreKory testified last week at the Oklahoma state legislature. pic.twitter.com/sMWKk0NLWk

— Mary Talley Bowden MD (@MdBreathe) October 21, 2024

Would You Refuse a Safe Drug in the ICU?

Imagine yourself in the intensive care unit, fighting for your life against COVID-19. Would you refuse to try a safe drug that has shown an 81% decrease in mortality rates? This is the question that many patients and healthcare professionals are grappling with in the midst of the ongoing pandemic.

One of the drugs that has been at the center of controversy is ivermectin. Despite some studies showing promising results in reducing mortality rates among COVID-19 patients, there has been a war on ivermectin, leading to confusion and skepticism among the public. The debate around the use of ivermectin has even led to claims that millions of deaths could have been prevented if the drug had been more widely accepted and prescribed.

What Does the Evidence Say?

Dr. Pierre Kory, a critical care physician, testified at the Oklahoma state legislature about the potential benefits of ivermectin in treating COVID-19. He presented data and studies that showed a significant decrease in mortality rates among patients who were treated with ivermectin compared to those who were not.

However, the medical community remains divided on the use of ivermectin for COVID-19. Some experts argue that more rigorous clinical trials are needed to definitively prove the drug’s efficacy, while others believe that the existing evidence is strong enough to support its use in certain cases.

Is the War on Ivermectin Justified?

The question of whether the war on ivermectin is justified is a complex one. On one hand, there is a need for caution when it comes to prescribing medications for off-label use, especially in the midst of a global health crisis. On the other hand, if a drug has the potential to save lives and reduce the burden on healthcare systems, should it not be considered as a viable treatment option?

The controversy surrounding ivermectin highlights the challenges of navigating the ever-evolving landscape of COVID-19 treatments. As new information emerges and the scientific community continues to learn more about the virus, it is important to approach potential treatments with an open mind and a willingness to adapt based on the best available evidence.

In conclusion, the decision to try a drug like ivermectin in the ICU is a deeply personal one that should be made in consultation with healthcare professionals. While the evidence may be promising, it is essential to weigh the potential benefits against the risks and uncertainties. As we continue to navigate the challenges of the COVID-19 pandemic, maintaining an open dialogue and a spirit of collaboration will be key in finding effective treatments and ultimately saving lives.

Sources:
– @PierreKory
– Mary Talley Bowden MD’s Tweet